![ribosome_banner_07.11.24.jpg](/uploads/ribosome_banner_07_11_24_ac33fd11e4.jpg)

**Synopsis**

The International Conference on Ribosome Synthesis will be held in Cambridge, UK, from September 7 – 12, 2025, and will bring together approximately 200 biomedical researchers. The researchers will share and discuss their latest investigations on how the cellular protein factories called ribosomes are assembled. Participants will explore new strategies to target the process of ribosome synthesis to develop novel therapeutics for devastating diseases, including bone marrow failure disorders caused by mutations in ribosome synthesis factors and common forms of cancer. Researchers investigating the formation of bacterial ribosomes will also attend this conference, aiming to inform the development of new strategies to kill bacteria by targeting this process through the development of novel antibiotics.

The participants, including trainees, will represent a wide range of disciplines, from molecular biology to clinicians and industry representatives. This conference will facilitate the exchange of the latest research methods and results, inspiring the delivery of future strategies in biomedical and translational research. It will also contribute to training the next generation of researchers and enable the formation of productive new interdisciplinary collaborations. Ultimately, this conference aims to promote the development of new treatment strategies for cancer, bacterial infection and inherited diseases.

[For more informations please visit the webpage.](https://www.eventsforce.net/hg3/frontend/reg/thome.csp?pageID=126198&ef_sel_menu=2378&eventID=317) 


https://www.haem.cam.ac.uk/events/ribosome-synthesis-conference-september-2025


The International Conference on Ribosome Synthesis will be held in Cambridge, UK, from September 7 – 12, 2025.

ribosome_banner_c.png

The International Conference on Ribosome Synthesis in Cambridge, UK

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

The International Conference on Ribosome Synthesis in Cambridge, UK